Clinical Trials Search | Clareo Health

RECRUITINGPhase 2/3

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

NCT07001800

The purpose of this study is to evaluate if ataciguat slows the progression of moderate calcific aortic valve stenosis in adults.

Moderate Aortic Valve Stenosis

Kardigan, Inc.1,276 participantsStarted Jun 2025

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Peoria, Arizona, United States +67 more locations

Active Not RecruitingNA

Evolut™ EXPAND TAVR II Pivotal Trial

NCT05149755

Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.

Moderate Aortic Valve Stenosis

Medtronic Cardiovascular650 participantsStarted Apr 2022

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +91 more locations

WITHDRAWNNA

Aortic Valve Replacement for Moderate Aortic Stenosis With Left Ventricular Decompensation Early Feasibility Study

NCT07060183

Obtain safety and effectiveness data to support expansion for aortic valve replacement to include patients with moderate aortic stenosis and left ventricular decompensation.

Moderate Aortic Valve Stenosis

Dermed Diagnostics, Inc.Started Jan 2027

Filters

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

Evolut™ EXPAND TAVR II Pivotal Trial

Aortic Valve Replacement for Moderate Aortic Stenosis With Left Ventricular Decompensation Early Feasibility Study

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

Evolut™ EXPAND TAVR II Pivotal Trial

Aortic Valve Replacement for Moderate Aortic Stenosis With Left Ventricular Decompensation Early Feasibility Study